Vasculitis sistémicas

Publicaciones destacadas

Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis

Steinfeld, Jonathan; Bradford, Eric S; Brown, Judith; Mallett, Stephen; Yancey, Steven W;

(...)

Merkel, Peter A; Moosig, Frank; Specks, Ulrich; Weller, Peter F; Wechsler, Michael E.

Referencia:
Journal Of Allergy And Clinical Immunology 2019.
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

Jones, RB; Hiemstra, TF; Ballarin, J; Blockmans, DE; Brogan, P;

(...)

Baildam, E; Stoves, J; Erwig, L; Christian, M; Savage, CO.

Referencia:
Annals Of The Rheumatic Diseases 2019.
Expression and function of IL12/23 related cytokine subunits (p35, p40, and p19) in giant-cell arteritis lesions: Contribution of p40 to Th1-and Th17-mediated inflammatory pathways

Espigol-Frigolé, G; Planas-Rigol, E; Lozano, E; Corbera-Bellalta, M; Terrades-García, N;

Prieto-González, S; García-Martínez, A; Hernández-Rodríguez, J; Grau, JM; Cid, MC.

Referencia:
Frontiers In Immunology 2018.
Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: A mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis

Planas-Rigol, E; Terrades-Garcia, N; Corbera-Bellalta, M; Lozano, E; Alba, MA;

(...)

Prieto-González, S; Hernández-Rodríguez, J; Preciado, S; Lavilla, R; Cid, MC.

Referencia:
Annals Of The Rheumatic Diseases 2017.
Trial of Tocilizumab in Giant-Cell Arteritis.

Stone JH; Tuckwell K; Dimonaco S; Klearman M; Aringer M;

(...)

Schett G; Schulze-Koops H; Spiera R; Unizony SH; Collinson N .

Referencia:
New England Journal Of Medicine 2017.
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Wechsler, M E; Akuthota, P; Jayne, D; Khoury, P; Klion, A;

(...)

Philipson, R; Yancey, S W; Steinfeld, J; Weller, P F; Gleich, G J;EGPA Mepolizumab Study Team.

Referencia:
New England Journal Of Medicine 2017.
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Carmona FD; Vaglio A; Mackie SL; Hernández-Rodríguez J; Monach PA;

(...)

Morgan AW; González-Gay MA; Martín J Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium.

Referencia:
American Journal Of Human Genetics 2017.
Blocking interferon gamma reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis

Corbera-Bellalta, M; Planas-Rigol, E; Lozano, E; Terrades-García, N; Alba, MA;

(...)

Roux-Lombard, P; Ferlin, WG; Dayer, JM; Kosco-Vilbois, MH; Cid, MC.

Referencia:
Annals Of The Rheumatic Diseases 2016.
Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling

Espígol-Frigolé, G; Planas-Rigol, E; Ohnuki, H; Salvucci, O; Kwak, H;

Ravichandran, S; Luke, B; Cid, MC; Tosato, G.

Referencia:
Science Signaling 2016.
Changes in biomarkers after therapeutic intervention in temporal arteries cell arteritis

Corbera-Bellalta, M; García-Martínez, A; Lozano, E; Planas-Rigol, E; Tavera-Bahillo, I;

(...)

Fernández, PL; Roux-Lombard, P; Dayer, JM; Rahman, MU; Cid, MC.

Referencia:
Annals Of The Rheumatic Diseases 2014.